Journal of Multiple Sclerosis and Neuroimmunology

Search

Page Path

HOME
Search

Case Report

한국 시신경척수염 환자에서 1차 치료제로서의 Rituximab 비용 효율 연구: 현재원, 장현민, 박정미, 이민영, 김수현, 김호진; J Mult Scler Neuroimmunol. 2020;11(2):53-58. Published online December 1, 2020; PDF

Volume 16, No. 1

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

7,920	Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
4,627	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
4,065	National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
3,786	Rituximab Treatment for Neuroimmunologic Disorders
3,242	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review

Cited By 4	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review
Cited By 1	National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Cited By 1	A Case of Post-Infective Myelin-Oligodendrocyte Glycoprotein Antibody-Associated Disease
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: jmsni@koreams.org

Copyright © 2025 by Korean Society of Neuroimmunology.